Robert A Hamm Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert A Hamm.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert A Hamm. Robert A Hamm is Chief Operating Officer in BIOGEN INC. ($IDPH) and EVP, Pharma. Oper. & Tech. in BIOGEN INC. ($IDPH) and SVP, Immunology Business Unit in BIOGEN INC. ($IDPH) and SVP, Neurology SBU in BIOGEN INC. ($IDPH).
Latest Insider Trading Transactions of Robert A Hamm
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 57.52 | 510 | 29,335 | 29,256 | 29.8 K to 29.3 K (-1.71 %) |
| Apr 05 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 57.52 | 505 | 29,048 | 29,766 | 30.3 K to 29.8 K (-1.67 %) |
| Apr 26 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 52.19 | 703 | 36,690 | 27,212 | 27.9 K to 27.2 K (-2.52 %) |
| Apr 26 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 52.16 | 710 | 37,032 | 27,915 | 28.6 K to 27.9 K (-2.48 %) |
| Apr 26 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 52.20 | 2,138 | 111,603 | 28,625 | 30.8 K to 28.6 K (-6.95 %) |
| Apr 26 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 52.20 | 2,117 | 110,504 | 30,763 | 32.9 K to 30.8 K (-6.44 %) |
| Feb 25 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Option Exercise | A | 0.00 | 48,916 | 0 | 48,916 | |
| Feb 25 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 55.29 | 996 | 55,069 | 30,271 | 31.3 K to 30.3 K (-3.19 %) |
| Feb 25 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 55.29 | 985 | 54,461 | 31,267 | 32.3 K to 31.3 K (-3.05 %) |
| Feb 25 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Grant | A | 0.00 | 9,306 | 0 | 32,252 | 22.9 K to 32.3 K (+40.56 %) |
| Feb 19 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 56.16 | 3,387 | 190,198 | 22,946 | 26.3 K to 22.9 K (-12.86 %) |
| Feb 19 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 56.15 | 3,194 | 179,358 | 26,333 | 29.5 K to 26.3 K (-10.82 %) |
| Feb 17 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 55.21 | 1,486 | 82,042 | 29,527 | 31 K to 29.5 K (-4.79 %) |
| Feb 17 2010 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 55.21 | 1,613 | 89,054 | 31,013 | 32.6 K to 31 K (-4.94 %) |
| Nov 05 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 42.84 | 524 | 22,449 | 32,626 | 33.2 K to 32.6 K (-1.58 %) |
| Nov 05 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 42.80 | 2,330 | 99,724 | 33,150 | 35.5 K to 33.2 K (-6.57 %) |
| Nov 03 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 42.13 | 1,670 | 70,357 | 35,480 | 37.2 K to 35.5 K (-4.50 %) |
| Nov 03 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Payment of Exercise | F | 42.13 | 376 | 15,841 | 37,150 | 37.5 K to 37.2 K (-1.00 %) |
| Jun 24 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 50.77 | 1,000 | 50,768 | 37,526 | 38.5 K to 37.5 K (-2.60 %) |
| Jun 24 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Sell | S | 49.75 | 2,194 | 109,143 | 38,526 | 40.7 K to 38.5 K (-5.39 %) |
| Apr 02 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Option Exercise | A | 51.88 | 9,740 | 505,311 | 9,740 | |
| Apr 02 2009 | IDPH | BIOGEN INC. | Hamm Robert A | Chief Operating Off ... | Grant | A | 0.00 | 3,660 | 0 | 40,720 | 37.1 K to 40.7 K (+9.88 %) |
| Feb 26 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | A | 49.65 | 25,000 | 1,241,250 | 25,000 | |
| Feb 26 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Grant | A | 0.00 | 9,400 | 0 | 37,060 | 27.7 K to 37.1 K (+33.98 %) |
| Feb 20 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 50.90 | 3,412 | 173,675 | 27,660 | 31.1 K to 27.7 K (-10.98 %) |
| Feb 17 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Payment of Exercise | F | 52.61 | 1,588 | 83,545 | 31,072 | 32.7 K to 31.1 K (-4.86 %) |
| Feb 17 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Payment of Exercise | F | 52.61 | 1,486 | 78,178 | 32,660 | 34.1 K to 32.7 K (-4.35 %) |
| Feb 13 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 50.76 | 3,670 | 186,282 | 34,146 | 37.8 K to 34.1 K (-9.70 %) |
| Feb 10 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 0.00 | 5,466 | 0 | 0 | |
| Feb 10 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Payment of Exercise | F | 52.48 | 1,796 | 94,254 | 37,816 | 39.6 K to 37.8 K (-4.53 %) |
| Feb 10 2009 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 0.00 | 5,466 | 0 | 39,612 | 34.1 K to 39.6 K (+16.01 %) |
| Nov 07 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 44.61 | 525 | 23,420 | 34,146 | 34.7 K to 34.1 K (-1.51 %) |
| Nov 07 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 44.96 | 200 | 8,992 | 34,671 | 34.9 K to 34.7 K (-0.57 %) |
| Nov 07 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 44.53 | 2,130 | 94,842 | 34,871 | 37 K to 34.9 K (-5.76 %) |
| Nov 04 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Payment of Exercise | F | 42.55 | 2,045 | 87,015 | 37,001 | 39 K to 37 K (-5.24 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 37.45 | 20,124 | 753,644 | 0 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 49.03 | 10,062 | 493,340 | 0 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 45.46 | 5,750 | 261,395 | 0 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 62.28 | 28,750 | 1,790,550 | 0 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 49.31 | 9,725 | 479,540 | 29,175 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 44.24 | 20,450 | 904,708 | 20,450 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 67.57 | 33,750 | 2,280,488 | 11,250 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 43.50 | 27,475 | 1,195,163 | 0 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 70.00 | 156,086 | 10,926,020 | 39,046 | 195.1 K to 39 K (-79.99 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 43.50 | 27,475 | 1,195,163 | 195,132 | 167.7 K to 195.1 K (+16.39 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 37.45 | 20,124 | 753,644 | 167,657 | 147.5 K to 167.7 K (+13.64 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 49.03 | 10,062 | 493,340 | 147,533 | 137.5 K to 147.5 K (+7.32 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 67.57 | 33,750 | 2,280,488 | 137,471 | 103.7 K to 137.5 K (+32.54 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 45.46 | 5,750 | 261,395 | 103,721 | 98 K to 103.7 K (+5.87 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 62.28 | 28,750 | 1,790,550 | 97,971 | 69.2 K to 98 K (+41.53 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 49.31 | 9,725 | 479,540 | 69,221 | 59.5 K to 69.2 K (+16.35 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 44.24 | 20,450 | 904,708 | 59,496 | 39 K to 59.5 K (+52.37 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 64.23 | 400 | 25,692 | 39,046 | 39.4 K to 39 K (-1.01 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 64.22 | 13 | 835 | 39,446 | 39.5 K to 39.4 K (-0.03 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 64.13 | 3 | 192 | 39,459 | 39.5 K to 39.5 K (-0.01 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 64.09 | 100 | 6,409 | 39,462 | 39.6 K to 39.5 K (-0.25 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 64.07 | 297 | 19,029 | 39,562 | 39.9 K to 39.6 K (-0.75 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.95 | 400 | 25,580 | 39,859 | 40.3 K to 39.9 K (-0.99 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.87 | 100 | 6,387 | 40,259 | 40.4 K to 40.3 K (-0.25 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.80 | 100 | 6,380 | 40,359 | 40.5 K to 40.4 K (-0.25 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.79 | 100 | 6,379 | 40,459 | 40.6 K to 40.5 K (-0.25 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.75 | 700 | 44,625 | 40,559 | 41.3 K to 40.6 K (-1.70 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.72 | 200 | 12,744 | 41,259 | 41.5 K to 41.3 K (-0.48 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.70 | 200 | 12,740 | 41,459 | 41.7 K to 41.5 K (-0.48 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.55 | 200 | 12,710 | 41,659 | 41.9 K to 41.7 K (-0.48 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.54 | 100 | 6,354 | 41,859 | 42 K to 41.9 K (-0.24 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.51 | 200 | 12,702 | 41,959 | 42.2 K to 42 K (-0.47 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.49 | 200 | 12,698 | 42,159 | 42.4 K to 42.2 K (-0.47 %) |
| Apr 17 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 63.48 | 100 | 6,348 | 42,359 | 42.5 K to 42.4 K (-0.24 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | A | 60.56 | 39,320 | 2,381,219 | 39,320 | |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 61.41 | 100 | 6,141 | 28,419 | 28.5 K to 28.4 K (-0.35 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 61.20 | 300 | 18,360 | 28,519 | 28.8 K to 28.5 K (-1.04 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 61.06 | 600 | 36,636 | 28,819 | 29.4 K to 28.8 K (-2.04 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 61.02 | 100 | 6,102 | 29,419 | 29.5 K to 29.4 K (-0.34 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 61.00 | 700 | 42,700 | 29,519 | 30.2 K to 29.5 K (-2.32 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.94 | 100 | 6,094 | 30,219 | 30.3 K to 30.2 K (-0.33 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.93 | 100 | 6,093 | 30,319 | 30.4 K to 30.3 K (-0.33 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.88 | 79 | 4,810 | 30,419 | 30.5 K to 30.4 K (-0.26 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.86 | 100 | 6,086 | 30,498 | 30.6 K to 30.5 K (-0.33 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.81 | 400 | 24,324 | 30,598 | 31 K to 30.6 K (-1.29 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.78 | 200 | 12,156 | 30,998 | 31.2 K to 31 K (-0.64 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.77 | 303 | 18,413 | 31,198 | 31.5 K to 31.2 K (-0.96 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.74 | 97 | 5,892 | 31,501 | 31.6 K to 31.5 K (-0.31 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.73 | 200 | 12,146 | 31,598 | 31.8 K to 31.6 K (-0.63 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Sell | S | 60.49 | 300 | 18,147 | 31,798 | 32.1 K to 31.8 K (-0.93 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Grant | A | 0.00 | 14,040 | 0 | 42,459 | 28.4 K to 42.5 K (+49.40 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Payment of Exercise | F | 60.56 | 1,587 | 96,109 | 32,098 | 33.7 K to 32.1 K (-4.71 %) |
| Feb 07 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Option Exercise | M | 0.00 | 5,467 | 0 | 5,466 | |
| Feb 07 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Payment of Exercise | F | 60.52 | 2,335 | 141,314 | 33,138 | 35.5 K to 33.1 K (-6.58 %) |
| Feb 07 2008 | IDPH | BIOGEN INC. | Hamm Robert A | EVP, Pharma. Oper. ... | Buy | M | 0.00 | 5,467 | 0 | 35,473 | 30 K to 35.5 K (+18.22 %) |
| Nov 02 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Neurology SBU | Option Exercise | A | 72.87 | 6,900 | 502,803 | 6,900 | |
| Nov 02 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Neurology SBU | Grant | A | 0.00 | 14,700 | 0 | 30,006 | 15.3 K to 30 K (+96.04 %) |
| Apr 25 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Neurology SBU | Sell | S | 47.34 | 3,731 | 176,633 | 15,306 | 19 K to 15.3 K (-19.60 %) |
| Mar 22 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 44.48 | 5,077 | 225,819 | 19,037 | 24.1 K to 19 K (-21.05 %) |
| Mar 16 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Payment of Exercise | F | 44.11 | 3,638 | 160,472 | 24,114 | 27.8 K to 24.1 K (-13.11 %) |
| Mar 16 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Grant | A | 0.00 | 8,715 | 0 | 27,752 | 19 K to 27.8 K (+45.78 %) |
| Feb 15 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 49.22 | 6,188 | 304,549 | 19,037 | 25.2 K to 19 K (-24.53 %) |
| Feb 14 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Option Exercise | A | 49.31 | 38,900 | 1,918,159 | 38,900 | |
| Feb 14 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Grant | A | 0.00 | 15,000 | 0 | 25,225 | 10.2 K to 25.2 K (+146.70 %) |
| Feb 08 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Option Exercise | D | 0.00 | 5,467 | 0 | 10,933 | |
| Feb 08 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Payment of Exercise | F | 48.94 | 4,706 | 230,312 | 10,255 | 15 K to 10.3 K (-31.46 %) |
| Feb 08 2007 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Buy | M | 0.00 | 5,467 | 0 | 14,961 | 9.5 K to 15 K (+57.58 %) |
| Sep 20 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 42.70 | 1,045 | 44,622 | 9,494 | 10.5 K to 9.5 K (-9.92 %) |
| Sep 20 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 42.72 | 1,516 | 64,759 | 10,540 | 12.1 K to 10.5 K (-12.57 %) |
| Sep 20 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 42.75 | 3,411 | 145,835 | 12,056 | 15.5 K to 12.1 K (-22.05 %) |
| Sep 20 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 42.77 | 3,411 | 145,888 | 15,467 | 18.9 K to 15.5 K (-18.07 %) |
| Sep 20 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 42.80 | 3,411 | 145,991 | 18,879 | 22.3 K to 18.9 K (-15.30 %) |
| Sep 20 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Sell | S | 42.84 | 3,411 | 146,126 | 22,290 | 25.7 K to 22.3 K (-13.27 %) |
| Sep 15 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Payment of Exercise | F | 43.39 | 8,293 | 359,833 | 25,701 | 34 K to 25.7 K (-24.40 %) |
| Sep 15 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Grant | A | 0.00 | 24,500 | 0 | 33,994 | 9.5 K to 34 K (+258.06 %) |
| Feb 08 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Option Exercise | A | 0.00 | 16,400 | 0 | 16,400 | |
| Feb 08 2006 | IDPH | BIOGEN INC. | Hamm Robert A | SVP, Immunology Bus ... | Option Exercise | A | 44.24 | 40,900 | 1,809,416 | 40,900 |
Page: 1